R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma
β Scribed by Tomita, Naoto; Takasaki, Hirotaka; Miyashita, Kazuho; Fujisawa, Shin; Ogusa, Eriko; Matsuura, Shiro; Kishimoto, Kumiko; Numata, Ayumi; Fujita, Atsuko; Ohshima, Rika; Kuwabara, Hideyuki; Hagihara, Maki; Hashimoto, Chizuko; Takemura, Sachiya; Koharazawa, Hideyuki; Yamazaki, Etsuko; Fujimaki, Katsumichi; Taguchi, Jun; Sakai, Rika; Ishigatsubo, Yoshiaki
- Book ID
- 120227081
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 146 KB
- Volume
- 161
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct